Solid Biosciences Llc Stock Technical Analysis

SLDB Stock  USD 6.86  0.34  5.21%   
As of the 10th of February, Solid Biosciences has the Coefficient Of Variation of 612.75, risk adjusted performance of 0.1392, and Semi Deviation of 3.24. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Solid Biosciences LLC, as well as the relationship between them.

Solid Biosciences Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Solid, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to SolidSolid Biosciences' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Solid Biosciences Analyst Consensus

Target PriceConsensus# of Analysts
15.75Strong Buy12Odds
Solid Biosciences LLC current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Solid analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Solid stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Solid Biosciences LLC, talking to its executives and customers, or listening to Solid conference calls.
Solid Analyst Advice Details
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Solid Biosciences. If investors know Solid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Solid Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(2.48)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.44)
Return On Equity
(0.87)
Understanding Solid Biosciences LLC requires distinguishing between market price and book value, where the latter reflects Solid's accounting equity. The concept of intrinsic value - what Solid Biosciences' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Solid Biosciences' price substantially above or below its fundamental value.
Please note, there is a significant difference between Solid Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Solid Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Solid Biosciences' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.

Solid Biosciences 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Solid Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Solid Biosciences.
0.00
11/12/2025
No Change 0.00  0.0 
In 2 months and 31 days
02/10/2026
0.00
If you would invest  0.00  in Solid Biosciences on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding Solid Biosciences LLC or generate 0.0% return on investment in Solid Biosciences over 90 days. Solid Biosciences is related to or competes with GeoVax Labs, BioLineRx, Tharimmune, Ainos, and Lipocine. Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States More

Solid Biosciences Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Solid Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Solid Biosciences LLC upside and downside potential and time the market with a certain degree of confidence.

Solid Biosciences Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Solid Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Solid Biosciences' standard deviation. In reality, there are many statistical measures that can use Solid Biosciences historical prices to predict the future Solid Biosciences' volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Solid Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
2.226.7411.26
Details
Intrinsic
Valuation
LowRealHigh
4.398.9113.43
Details
12 Analysts
Consensus
LowTargetHigh
14.3315.7517.48
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.73-0.53-0.46
Details

Solid Biosciences February 10, 2026 Technical Indicators

Solid Biosciences LLC Backtested Returns

Solid Biosciences appears to be slightly risky, given 3 months investment horizon. Solid Biosciences LLC owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.16, which indicates the firm had a 0.16 % return per unit of risk over the last 3 months. By inspecting Solid Biosciences' technical indicators, you can evaluate if the expected return of 0.72% is justified by implied risk. Please review Solid Biosciences' Risk Adjusted Performance of 0.1392, semi deviation of 3.24, and Coefficient Of Variation of 612.75 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Solid Biosciences holds a performance score of 12. The entity has a beta of 1.52, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Solid Biosciences will likely underperform. Please check Solid Biosciences' semi variance, rate of daily change, and the relationship between the value at risk and kurtosis , to make a quick decision on whether Solid Biosciences' existing price patterns will revert.

Auto-correlation

    
  0.76  

Good predictability

Solid Biosciences LLC has good predictability. Overlapping area represents the amount of predictability between Solid Biosciences time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Solid Biosciences LLC price movement. The serial correlation of 0.76 indicates that around 76.0% of current Solid Biosciences price fluctuation can be explain by its past prices.
Correlation Coefficient0.76
Spearman Rank Test0.57
Residual Average0.0
Price Variance0.3
Solid Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Solid Biosciences technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Solid Biosciences trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Solid Biosciences LLC Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Solid Biosciences LLC across different markets.

About Solid Biosciences Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Solid Biosciences LLC on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Solid Biosciences LLC based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Solid Biosciences LLC price pattern first instead of the macroeconomic environment surrounding Solid Biosciences LLC. By analyzing Solid Biosciences's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Solid Biosciences's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Solid Biosciences specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2025 2026 (projected)
Interest Debt Per Share0.690.66
Revenue Per Share1.091.57

Solid Biosciences February 10, 2026 Technical Indicators

Most technical analysis of Solid help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Solid from various momentum indicators to cycle indicators. When you analyze Solid charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Solid Biosciences February 10, 2026 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Solid stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

Complementary Tools for Solid Stock analysis

When running Solid Biosciences' price analysis, check to measure Solid Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Solid Biosciences is operating at the current time. Most of Solid Biosciences' value examination focuses on studying past and present price action to predict the probability of Solid Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Solid Biosciences' price. Additionally, you may evaluate how the addition of Solid Biosciences to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Technical Analysis
Check basic technical indicators and analysis based on most latest market data